PROCEPT BioRobotics (PRCT) Shares Outstanding (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Shares Outstanding (Entity) came in at $57.2 million in Q2 2026, up 3.0% year-over-year from $55.6 million in Q2 2025, and up 0.62% quarter-over-quarter from $56.9 million in Q1 2026.
Analysis
PROCEPT BioRobotics (PRCT) Shares Outstanding (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Shares Outstanding (Entity) for 7 consecutive years, with $57.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 3.0% year-over-year to $57.2 million in Q2 2026; TTM through Jun 2026 was $57.2 million, a 3.0% increase from a year earlier, with the FY2025 full-year figure at $56.3 million, up 2.93% from the prior year.
- Shares Outstanding (Entity) was $57.2 million for Q2 2026 at PROCEPT BioRobotics, up from $56.9 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $57.2 million in Q2 2026 and troughed at $44.1 million in Q1 2022.
- A 5-year average of $50.9 million and a median of $51.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) surged 744.87% in 2022 and rose 1.65% in 2023, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $44.8 million in 2022, then grew by 13.26% to $50.8 million in 2023, then advanced by 7.77% to $54.7 million in 2024, then advanced by 2.93% to $56.3 million in 2025, then gained by 1.64% to $57.2 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $57.2 million (Q2 2026), $56.9 million (Q1 2026), and $56.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 97.60 Mn |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | 57.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.07 Mn |
| Mar 31, 2026 | 56.51 Mn |
| Dec 31, 2025 | 55.54 Mn |
| Sep 30, 2025 | 55.73 Mn |
| Jun 30, 2025 | 55.45 Mn |
| Mar 31, 2025 | 54.92 Mn |
| Dec 31, 2024 | 52.13 Mn |
| Sep 30, 2024 | 52.01 Mn |
| Jun 30, 2024 | 51.62 Mn |
| Mar 31, 2024 | 51.01 Mn |
| Dec 31, 2023 | 47.26 Mn |
| Sep 30, 2023 | 48.31 Mn |
| Jun 30, 2023 | 45.16 Mn |
| Mar 31, 2023 | 45.07 Mn |
| Dec 31, 2022 | 44.40 Mn |
| Sep 30, 2022 | 44.64 Mn |
| Jun 30, 2022 | 44.32 Mn |
| Mar 31, 2022 | 43.86 Mn |
| Dec 31, 2021 | 16.48 Mn |
| Sep 30, 2021 | 11.58 Mn |